Speir E, Huang E S, Modali R, Leon M B, Shawl F, Finkel T, Epstein S E
Cardiology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Scand J Infect Dis Suppl. 1995;99:78-81.
Restenosis occurs in 25-50% of patients. Within 1-6 months after coronary angioplasty, excessive injury-induced smooth muscle cell (SMC) proliferation contributes to the development of restenosis; its causes remain unknown. The results of this study implicate human cytomegalovirus (HCMV) and HCMV-induced abnormalities in p53 function in the restenosis process. Almost 40% of restenosis lesions, obtained by atherectomy, demonstrated increased SMC p53 levels by p53 immunopositivity; sequencing revealed the p53 to be the wild type. A strong correlation was found between p53 immunopositivity and the presence of HCMV DNA. Moreover, the HCMV IE84 protein co-immunoprecipitates with p53, and p53 transcriptional capacity is reduced by IE84. Thus, HCMV may play a causal role in restenosis, which may be at least partly mediated by inhibiting p53 suppressor effects.
25%至50%的患者会出现再狭窄。在冠状动脉血管成形术后1至6个月内,过度损伤诱导的平滑肌细胞(SMC)增殖会导致再狭窄的发生;其病因尚不清楚。本研究结果表明,人类巨细胞病毒(HCMV)和HCMV诱导的p53功能异常参与了再狭窄过程。通过旋切术获得的近40%的再狭窄病变,经p53免疫阳性检测显示SMC p53水平升高;测序显示p53为野生型。发现p53免疫阳性与HCMV DNA的存在之间存在强烈相关性。此外,HCMV IE84蛋白与p53共免疫沉淀,且IE84会降低p53的转录能力。因此,HCMV可能在再狭窄中起因果作用,这可能至少部分是通过抑制p53的抑制作用介导的。